BAFMX
Price
$18.10
Change
-$0.03 (-0.17%)
Updated
Jan 24 closing price
Net Assets
74.32M
PEMGX
Price
$44.33
Change
+$0.01 (+0.02%)
Updated
Jan 24 closing price
Net Assets
29.98B
Ad is loading...

BAFMX vs PEMGX

Header iconBAFMX vs PEMGX Comparison
Open Charts BAFMX vs PEMGXBanner chart's image
Brown Advisory Mid-Cap Growth Instl
Price$18.10
Change-$0.03 (-0.17%)
VolumeN/A
Net Assets74.32M
Principal MidCap A
Price$44.33
Change+$0.01 (+0.02%)
VolumeN/A
Net Assets29.98B
BAFMX vs PEMGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BAFMX vs. PEMGX commentary
Jan 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAFMX is a StrongBuy and PEMGX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PEMGX has more cash in the bank: 30B vs. BAFMX (74.3M). BAFMX (0.00) and PEMGX (0.00) have matching dividends . BAFMX was incepted earlier than PEMGX: BAFMX (7 years) vs PEMGX (20 years). BAFMX is a more actively managed with annual turnover of: 55.00 vs. PEMGX (10.10). PEMGX has a lower initial minimum investment than BAFMX: PEMGX (1000) vs BAFMX (1000000). BAFMX annual gain was more profitable for investors over the last year : 22.80 vs. PEMGX (18.94). PEMGX return over 5 years is better than : 41.00 vs. BAFMX (26.04).
BAFMXPEMGXBAFMX / PEMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years20 years-
Gain YTD7.1644.012179%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets74.3M30B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year22.8018.94120%
Returns for 3 years21.5626.6281%
Returns for 5 years26.0441.0064%
Returns for 10 yearsN/A106.56-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEEP4.420.52
+13.33%
Mobile Infrastructure Corp
EXK3.670.09
+2.51%
Endeavour Silver Corp
BXP73.561.70
+2.37%
BXP Inc.
APGE40.280.07
+0.17%
Apogee Therapeutics
ZVSA1.48-0.03
-1.93%
ZyVersa Therapeutics